Expert Opinion on Biological Therapy 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 15, 2024 Category: Drugs & Pharmacology Authors: Dimitra StergianouTheodora KanniChristina DamoulariEvangelos J. Giamarellos-Bourboulis4th Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Athens, Greece Source Type: research
Correction
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 4, 2024 Category: Drugs & Pharmacology Source Type: research
Antimicrobial peptides in bone regeneration: mechanism and potential
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 3, 2024 Category: Drugs & Pharmacology Authors: ZhiCheng WangXiaoMan ChenLiang YanWenJie WangPeiJia ZhengAtashbahar MohammadrezaQi Liua Department of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, Chinab School of Stomatology, Southern Medical University, Guangzhou, Chinac Schoo Source Type: research
Effectiveness of biological therapy in reducing psoriasis-related cardiovascular risk
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - April 1, 2024 Category: Drugs & Pharmacology Authors: Sara BoskovicSilvia BorrielloFabrizio D ’AscenzoNadia SciamarrelliFrancois RossetLuca MastorinoDapavo PaoloPier Paolo BocchinoOvidio De FilippoSimone RiberoGaetano De FerrariPietro Quaglinoa Department of Medical Sciences, Section of Dermatology, Univer Source Type: research
Luspatercept in low-risk myelodysplastic syndromes: a paradigm shift in treatment strategies
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - March 31, 2024 Category: Drugs & Pharmacology Authors: Matteo MolicaMarco Rossia Department of Hematology-Oncology, Azienda Universitaria Ospedaliera Renato Dulbecco, Catanzaro, Italyb Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy Source Type: research
Global experience of faricimab in clinical settings - a review
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - March 29, 2024 Category: Drugs & Pharmacology Authors: Ashish SharmaNilesh KumarNikulaa ParachuriAnat LoewensteinFrancesco BandelloBaruch D Kuppermanna Lotus Eye Hospital and Institute, Coimbatore, Indiab Madhavi Netralaya, Ara, Indiac Department of Vitreoretina, Sankara eye Hospital, Coimbatore, Indiad Divis Source Type: research
IgG-VHH bispecific fusion antibodies: challenges and opportunities as therapeutic agents
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - March 28, 2024 Category: Drugs & Pharmacology Authors: Andreas V. MadsenPeter KristensenSteffen Goletza Department of Biotechnology and Biomedicine, Technical University of Denmark, Kgs. Lyngby, Denmarkb Department of Chemistry and Bioscience, Aalborg University, Aalborg, Denmark Source Type: research
Emerging anti-spike monoclonal antibodies against SARS-CoV-2
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - March 27, 2024 Category: Drugs & Pharmacology Authors: Eloy E. OrdayaRaymund R. RazonableDivision of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, MN, USA Source Type: research
CAR T cells for solid tumors – developments to watch in 2023
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - March 25, 2024 Category: Drugs & Pharmacology Authors: Marcel P. TrefnySebastian Kobolda Division of Clinical Pharmacology, University Hospital, Munich, Germanyb German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the University Hospital of the LMU, Germanyc Ein Source Type: research
Revolutionizing the management of patients with atopic dermatitis: practical considerations
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - March 25, 2024 Category: Drugs & Pharmacology Authors: Filomena RussoAnna Rita GiampetruzziMaria Antonietta PillaOrnella De Pit àElisa CamelaDepartment of Dermatology, IDI-IRCCS, Dermatological Research Hospital, Rome, Italy Source Type: research
Bispecific antibodies in immunotherapy for adult acute leukemia: latest updates from the 65th American Society of Hematology 2023 Annual Meeting
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - March 25, 2024 Category: Drugs & Pharmacology Authors: Lijie HanHaizhou XingWeijie CaoYongping SongZhongxing JiangJifeng YuDepartment of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China Source Type: research
Current and emerging monoclonal antibodies for treating familial hypercholesterolemia in children
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - March 21, 2024 Category: Drugs & Pharmacology Authors: M. Doortje ReijmanD. Meeike KustersAlbert WiegmanDepartment of Pediatrics, Amsterdam Cardiovascular Sciences, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands Source Type: research
Equity, expense, and expertise in biologic commissioning: adding the patient to the equation
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - March 21, 2024 Category: Drugs & Pharmacology Authors: Seb TucknottHelen McAteera IBDrelief Ltd, Brighton, UKb Psoriasis Association, Northampton, UK Source Type: research
The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - March 14, 2024 Category: Drugs & Pharmacology Authors: Hong De SaRichard T. MaziarzArpita P. GandhiCenter for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA Source Type: research
Tildrakizumab: the value of a personalized and flexible approach for treating moderate-to-severe plaque psoriasis in patients with high body weight or high disease burden
. (Source: Expert Opinion on Biological Therapy)
Source: Expert Opinion on Biological Therapy - March 6, 2024 Category: Drugs & Pharmacology Authors: Paolo DapavoMartina BurlandoClaudio GuarneriMatteo MegnaAlessandra NarcisiMarina TalamontiPaolo Gisondia Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italyb Clinica Dermatologica Ospedale Policlinico San Martino - IR Source Type: research
